As of 2026-03-30, the Relative Valuation of 9 Meters Biopharma Inc (NMTR) is (36.95) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.07 USD, the upside of 9 Meters Biopharma Inc based on Relative Valuation is -51270.4%.
The range of the Relative Valuation is (34.91) - (37.52) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.7x - 20.9x | 19.8x |
| Forward P/E multiples | 17.9x - 20.1x | 19.7x |
| Fair Price | (34.91) - (37.52) | (36.95) |
| Upside | -48446.3% - -52073.6% | -51270.4% |
| Date | P/E |